DIAGNOS Achieves Major Cybersecurity Milestone for its CARA System
BROSSARD, Quebec, April 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (DIAGNOS or the Corporation) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), recognized as a leader in the early detection of specific ophthalmic health issues through cutting-edge Artificial Intelligence (AI) technology, has announced significant advancements in cybersecurity certification for its CARA System application. This is a vital step in ensuring patient safety and data integrity in the healthcare sector.
As part of its rigorous ISO 27001 certification process, DIAGNOS is excited to share that the CARA System application has successfully completed a thorough series of penetration tests. These tests were conducted in line with the cybersecurity standards mandated by the Quebec Ministry of Health. In the wake of these assessments, any vulnerabilities that emerged were swiftly addressed following comprehensive regression tests carried out in early March 2025. The proactive measures taken by DIAGNOS have culminated in a favorable evaluation of CARA's security posture by the Cyber Defense Operational Center (COCD). This endorsement affirms DIAGNOS's compliance with the stringent cybersecurity protocols required in today's digital healthcare landscape.
In light of this certification progress, an official notification has been disseminated to Quebec's healthcare institutions, including the Integrated Health and Social Services Centers (CISSS) and the Integrated University Health and Social Services Centers (CIUSSS), as well as the Centre hospitalier de l'Universit de Montral (CHUM). These organizations have been authorized to incorporate the CARA system into their ongoing projects, thereby enhancing their diagnostic capabilities.
Andr Larente, the CEO of DIAGNOS, expressed the importance of this achievement, stating, Protecting personal data is at the heart of our commitment to our customers. The successful completion of our intrusion test validated by Quebec's Centre oprationnel de cyberscurit gouvernemental (COCD) is indisputable proof of the high level of security of our CARA application. This test marks a key step in our drive to obtain ISO 27001 certification. The planned verification audit will be decisive in confirming our ongoing efforts and commitment to the highest standards of cybersecurity. Our users can have total confidence in our rigorous standards to protect their information.
Furthermore, DIAGNOS is thrilled to report that its journey towards ISO 27001 certification is on track. Dates for audits with the certification body Intertek have been scheduled, and stakeholders can expect an update on this important milestone during the summer months.
About DIAGNOS
DIAGNOS is a publicly traded Canadian corporation dedicated to the early detection of critical eye-related health problems. By harnessing the power of Artificial Intelligence, DIAGNOS aims to furnish healthcare clinicians with enhanced diagnostic tools, ultimately improving workflow efficiency and patient outcomes on a global scale.
For further details, interested parties can visit
Robert Jackson
